Masimo, the health technology company that made headlines last winter over a dispute with Apple and its blood oxygen sensing technology, said Monday that its wearable Stork baby monitor is now cleared ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...

Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released ...

Furthering its move into the neonatal space, this morning non-invasive patient monitoring device and sensor maker Masimo announced that it landed FDA clearance for its acoustic respiration sensor, the ...

Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally poached its employees and stole trade secrets when developing the Apple ...

Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday, accusing the agency of improperly allowing Apple to import smartwatches with blood-oxygen reading ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

Following a decision that offered Apple a way to bring its Apple Watch blood oxygen tool back in the U.S., Bloomberg reports that Masimo alleges U.S. Customs and Border Protection "unlawfully let ...

Masimo is taking the U.S. government to court over its decision to allow blood oxygen tracking to return to the Apple Watch, saying its decision was unlawful and that Apple’s workaround still ...